• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

microRNA 表达分析:普萘洛尔的临床优势揭示了心肌梗死中的关键 microRNAs。

MicroRNA expression analysis: clinical advantage of propranolol reveals key microRNAs in myocardial infarction.

机构信息

Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

出版信息

PLoS One. 2011 Feb 28;6(2):e14736. doi: 10.1371/journal.pone.0014736.

DOI:10.1371/journal.pone.0014736
PMID:21386882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3046111/
Abstract

BACKGROUND

As playing important roles in gene regulation, microRNAs (miRNAs) are believed as indispensable involvers in the pathogenesis of myocardial infarction (MI) that causes significant morbidity and mortality. Working on a hypothesis that modulation of only some key members in the miRNA superfamily could benefit ischemic heart, we proposed a microarray based network biology approach to identify them with the recognized clinical effect of propranolol as a prompt.

METHODS

A long-term MI model of rat was established in this study. The microarray technology was applied to determine the global miRNA expression change intervened by propranolol. Multiple network analyses were sequentially applied to evaluate the regulatory capacity, efficiency and emphasis of the miRNAs which dysexpression in MI were significantly reversed by propranolol.

RESULTS

Microarray data analysis indicated that long-term propranolol administration caused 18 of the 31 dysregulated miRNAs in MI undergoing reversed expression, implying that intentional modulation of miRNA expression might show favorable effects for ischemic heart. Our network analysis identified that, among these miRNAs, the prime players in MI were miR-1, miR-29b and miR-98. Further finding revealed that miR-1 focused on regulation of myocyte growth, yet miR-29b and miR-98 stressed on fibrosis and inflammation, respectively.

CONCLUSION

Our study illustrates how a combination of microarray technology and functional protein network analysis can be used to identify disease-related key miRNAs.

摘要

背景

作为基因调控中发挥重要作用的 microRNAs(miRNAs),被认为是心肌梗死(MI)发病机制中不可或缺的参与者,导致了相当高的发病率和死亡率。基于这样一种假设,即仅对 miRNA 超家族中的某些关键成员进行调节就可能有益于缺血性心脏,我们提出了一种基于微阵列的网络生物学方法,并用普萘洛尔公认的临床疗效作为提示来识别它们。

方法

本研究建立了大鼠长期 MI 模型。应用微阵列技术来确定普萘洛尔干预下的全球 miRNA 表达变化。然后依次应用多种网络分析来评估 miRNA 的调控能力、效率和重点,这些 miRNA 在 MI 中的表达失调被普萘洛尔显著逆转。

结果

微阵列数据分析表明,长期普萘洛尔给药导致 MI 中 18 个失调 miRNA 中的 18 个表达发生逆转,这意味着有意调节 miRNA 表达可能对缺血性心脏有有利影响。我们的网络分析确定,在这些 miRNA 中,miR-1、miR-29b 和 miR-98 是 MI 中的主要调控者。进一步的研究发现,miR-1 主要集中在调节心肌细胞生长,而 miR-29b 和 miR-98 则分别强调纤维化和炎症。

结论

我们的研究说明了如何结合微阵列技术和功能蛋白质网络分析来识别与疾病相关的关键 miRNA。

相似文献

1
MicroRNA expression analysis: clinical advantage of propranolol reveals key microRNAs in myocardial infarction.microRNA 表达分析:普萘洛尔的临床优势揭示了心肌梗死中的关键 microRNAs。
PLoS One. 2011 Feb 28;6(2):e14736. doi: 10.1371/journal.pone.0014736.
2
MicroRNA and transcription factor mediated regulatory network analysis reveals critical regulators and regulatory modules in myocardial infarction.微小RNA与转录因子介导的调控网络分析揭示心肌梗死中的关键调控因子和调控模块。
PLoS One. 2015 Aug 10;10(8):e0135339. doi: 10.1371/journal.pone.0135339. eCollection 2015.
3
Identification of Myocardial Infarction-Associated Genes Using Integrative microRNA-Gene Expression Network Analysis.利用整合的 microRNA-基因表达网络分析鉴定心肌梗死相关基因。
DNA Cell Biol. 2021 Feb;40(2):348-358. doi: 10.1089/dna.2020.6222. Epub 2020 Dec 31.
4
Myocardial infarction unveiled: Key miRNA players screened by a novel lncRNA-miRNA-mRNA network model.心肌梗死揭秘:新型 lncRNA-miRNA-mRNA 网络模型筛选的关键 miRNA 靶点。
Comput Biol Med. 2023 Jun;160:106987. doi: 10.1016/j.compbiomed.2023.106987. Epub 2023 Apr 28.
5
MicroRNAs and cardiac sarcoplasmic reticulum calcium ATPase-2 in human myocardial infarction: expression and bioinformatic analysis.微小 RNA 与人心肌梗死肌浆网钙离子 ATP 酶 2:表达与生物信息学分析。
BMC Genomics. 2012 Oct 15;13:552. doi: 10.1186/1471-2164-13-552.
6
β-adrenoceptor regulates miRNA expression in rat heart.β-肾上腺素受体调节大鼠心脏中的 miRNA 表达。
Med Sci Monit. 2012 Aug;18(8):BR309-314. doi: 10.12659/msm.883263.
7
Functional Network Analysis Reveals Versatile MicroRNAs in Human Heart.功能网络分析揭示人类心脏中的多功能微小RNA。
Cell Physiol Biochem. 2015;36(4):1628-43. doi: 10.1159/000430324.
8
MiRNA and TF co-regulatory network analysis for the pathology and recurrence of myocardial infarction.用于心肌梗死病理和复发的微小RNA与转录因子共同调控网络分析
Sci Rep. 2015 Apr 13;5:9653. doi: 10.1038/srep09653.
9
MicroRNA microarray expression profiling in human myocardial infarction.人类心肌梗死中的 microRNA 微阵列表达谱分析。
Dis Markers. 2009;27(6):255-68. doi: 10.3233/DMA-2009-0671.
10
MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection.普萘洛尔下调心肌梗死后大鼠模型中 microRNA-1 的表达:一种新的缺血性心脏保护机制。
Cardiovasc Res. 2009 Dec 1;84(3):434-41. doi: 10.1093/cvr/cvp232. Epub 2009 Jul 6.

引用本文的文献

1
The Role of ncRNAs in Cardiac Infarction and Regeneration.非编码RNA在心肌梗死与再生中的作用
J Cardiovasc Dev Dis. 2023 Mar 15;10(3):123. doi: 10.3390/jcdd10030123.
2
Novel Role of miR-18a-5p and Galanin in Rat Lung Ischemia Reperfusion-Mediated Response.miR-18a-5p 和甘丙肽在大鼠肺缺血再灌注介导反应中的新作用。
Oxid Med Cell Longev. 2021 Aug 14;2021:6621921. doi: 10.1155/2021/6621921. eCollection 2021.
3
Exosomal miR-218-5p/miR-363-3p from Endothelial Progenitor Cells Ameliorate Myocardial Infarction by Targeting the p53/JMY Signaling Pathway.

本文引用的文献

1
Target mRNA abundance dilutes microRNA and siRNA activity.靶 mRNA 丰度使 microRNA 和 siRNA 活性降低。
Mol Syst Biol. 2010 Apr 20;6:363. doi: 10.1038/msb.2010.24.
2
miRSel: automated extraction of associations between microRNAs and genes from the biomedical literature.miRSel:从生物医学文献中自动提取 microRNA 和基因之间关联的方法。
BMC Bioinformatics. 2010 Mar 16;11:135. doi: 10.1186/1471-2105-11-135.
3
MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.微小 RNA:心血管疾病治疗靶点的新一类潜在候选物。
内皮祖细胞来源的外泌体 miR-218-5p/miR-363-3p 通过靶向 p53/JMY 信号通路改善心肌梗死。
Oxid Med Cell Longev. 2021 Jul 16;2021:5529430. doi: 10.1155/2021/5529430. eCollection 2021.
4
Role of the microRNA-29 family in myocardial fibrosis.miRNA-29 家族在心肌纤维化中的作用。
J Physiol Biochem. 2021 Aug;77(3):365-376. doi: 10.1007/s13105-021-00814-z. Epub 2021 May 28.
5
Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration.通过数据集成鉴定婴儿血管瘤和普萘洛尔治疗的潜在生物标志物。
Sci Rep. 2020 Feb 24;10(1):3261. doi: 10.1038/s41598-020-60025-2.
6
silencing by in postural tachycardia syndrome.在体位性心动过速综合征中通过 沉默。
JCI Insight. 2017 Mar 23;2(6):e90183. doi: 10.1172/jci.insight.90183.
7
MicroRNA-98 inhibits TGF-β1-induced differentiation and collagen production of cardiac fibroblasts by targeting TGFBR1.微小RNA-98通过靶向转化生长因子β受体1抑制转化生长因子β1诱导的心脏成纤维细胞分化和胶原蛋白生成。
Hum Cell. 2017 Jul;30(3):192-200. doi: 10.1007/s13577-017-0163-0. Epub 2017 Mar 1.
8
Β-blockers treatment of cardiac surgery patients enhances isolation and improves phenotype of cardiosphere-derived cells.β受体阻滞剂治疗心脏手术患者可增强心肌球衍生细胞的分离和改善其表型。
Sci Rep. 2016 Nov 14;6:36774. doi: 10.1038/srep36774.
9
Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma.内皮细胞和循环 C19MC microRNAs 是婴儿血管瘤的生物标志物。
JCI Insight. 2016 Sep 8;1(14):e88856. doi: 10.1172/jci.insight.88856.
10
miRNome in myocardial infarction: Future directions and perspective.心肌梗死中的微小RNA组:未来方向与展望
World J Cardiol. 2014 Sep 26;6(9):939-58. doi: 10.4330/wjc.v6.i9.939.
Acta Pharmacol Sin. 2010 Jan;31(1):1-9. doi: 10.1038/aps.2009.175. Epub 2009 Dec 7.
4
PerturbationAnalyzer: a tool for investigating the effects of concentration perturbation on protein interaction networks.扰动分析器:一种用于研究浓度扰动对蛋白质相互作用网络影响的工具。
Bioinformatics. 2010 Jan 15;26(2):275-7. doi: 10.1093/bioinformatics/btp634. Epub 2009 Nov 13.
5
MicroRNA-98 and let-7 confer cholangiocyte expression of cytokine-inducible Src homology 2-containing protein in response to microbial challenge.微小RNA-98和let-7在应对微生物挑战时赋予胆管细胞细胞因子诱导含Src同源2蛋白的表达。
J Immunol. 2009 Aug 1;183(3):1617-24. doi: 10.4049/jimmunol.0804362. Epub 2009 Jul 10.
6
MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection.普萘洛尔下调心肌梗死后大鼠模型中 microRNA-1 的表达:一种新的缺血性心脏保护机制。
Cardiovasc Res. 2009 Dec 1;84(3):434-41. doi: 10.1093/cvr/cvp232. Epub 2009 Jul 6.
7
MicroRNAs and cardiac pathology.微小RNA与心脏病理学
Nat Rev Cardiol. 2009 Jun;6(6):419-29. doi: 10.1038/nrcardio.2009.56.
8
MicroRNAs as a therapeutic target for cardiovascular diseases.微小RNA作为心血管疾病的治疗靶点。
J Cell Mol Med. 2009 Apr;13(4):778-89. doi: 10.1111/j.1582-4934.2009.00744.x. Epub 2009 Mar 13.
9
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.利用DAVID生物信息学资源对大型基因列表进行系统和综合分析。
Nat Protoc. 2009;4(1):44-57. doi: 10.1038/nprot.2008.211.
10
MicroRNAs in organogenesis and disease.器官发生与疾病中的微小RNA
Curr Mol Med. 2008 Dec;8(8):698-710. doi: 10.2174/156652408786733739.